Reports for SANOFI-AVENTIS CANADA INC
Company Name
SANOFI-AVENTIS CANADA INC
Totals |
||
Shortage reports |
271 |
|
| Actual shortage: | 6 (2%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 14 (5%) | |
| Resolved: | 251 (93%) | |
Discontinuation Reports |
49 |
|
| To be discontinued: | 5 (10%) | |
| Discontinued: | 44 (90%) | |
| Reversed: | 0 (0%) | |
Late reports |
20 (6%) |
|
Overdue reports |
4 (36%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APIDRA | 100UNIT | SOLUTION | Resolved | 2022-08-26 | 2022-09-14 | 168019 |
| APIDRA | 100UNIT | SOLUTION | Resolved | 2022-09-27 | 2022-10-12 | 170358 |
| APIDRA | 100UNIT | SOLUTION | Resolved | 2022-10-18 | 2023-07-12 | 172103 |
| APIDRA | 100UNIT | SOLUTION | Resolved | 2021-11-22 | 2021-11-24 | 149719 |
| APIDRA | 100UNIT | SOLUTION | Resolved | 2022-01-21 | 2022-02-03 | 153367 |
| APIDRA | 100UNIT | SOLUTION | Resolved | 2022-05-17 | 2022-06-02 | 160847 |
| APIDRA | 100UNIT | SOLUTION | Resolved | 2022-06-29 | 2022-09-26 | 163664 |
| APIDRA | 100UNIT | SOLUTION | Resolved | 2022-10-31 | 2023-07-12 | 173205 |
| ARAVA | 10MG | TABLET | Resolved | 2022-08-02 | 2023-01-27 | 165914 |
| ARAVA | 10MG | TABLET | Resolved | 2023-07-19 | 2023-11-28 | 199224 |
| ARAVA | 20MG | TABLET | Resolved | 2023-02-15 | 2023-06-14 | 184712 |
| ARAVA | 10MG | TABLET | Resolved | 2019-11-29 | 2020-04-25 | 100069 |
| ARAVA | 20MG | TABLET | Resolved | 2019-11-29 | 2020-04-25 | 100066 |
| ARAVA | 20MG | TABLET | Resolved | 2020-11-16 | 2020-12-02 | 128414 |
| AVALIDE | 12.5MG 150MG | TABLET | Resolved | 2018-12-20 | 2019-02-27 | 70230 |
| AVALIDE | 12.5MG 150MG | TABLET | Resolved | 2019-10-09 | 2020-01-24 | 95800 |
| AVALIDE | 150MG 12.5MG | TABLET | Resolved | 2021-01-28 | 2021-03-20 | 132678 |
| AVALIDE | 12.5MG 300MG | TABLET | Resolved | 2019-02-08 | 2019-03-02 | 75166 |
| AVALIDE | 12.5MG 300MG | TABLET | Resolved | 2019-05-08 | 2019-05-10 | 83440 |
| AVALIDE | 12.5MG 300MG | TABLET | Resolved | 2019-07-16 | 2020-01-24 | 89482 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| FLAGYL | 10% | CREAM | To be discontinued | 2024-03-28 | 2024-03-28 | 223877 |
| IMOVANE | 5.0MG | TABLET | To be discontinued | 2022-05-16 | 2022-05-16 | 160688 |
| JEVTANA | 40MG | SOLUTION | Discontinued | 2023-06-21 | 2023-09-13 | 196086 |
| KEVZARA | 150MG | SOLUTION | Discontinued | 2022-07-12 | 2022-08-02 | 164491 |
| LIBTAYO | 250MG | SOLUTION | Discontinued | 2023-12-06 | 2023-12-09 | 212566 |
| MYOCHRYSINE | 10MG | SOLUTION | Discontinued | 2019-06-10 | 2019-06-10 | 86067 |
| MYOCHRYSINE | 25MG | SOLUTION | Discontinued | 2019-06-10 | 2019-06-10 | 86070 |
| MYOCHRYSINE | 50MG | SOLUTION | Discontinued | 2019-06-10 | 2019-06-10 | 86073 |
| NOVAHISTEX DH | 20MG 5MG | SYRUP | Discontinued | 2019-11-11 | 2020-08-04 | 98371 |
| NOVAHISTEX DH | 20MG 5MG | SYRUP | Discontinued | 2019-11-11 | 2020-08-04 | 98374 |
| NOVAHISTINE DH | 10MG 1.7MG | SYRUP | Discontinued | 2019-11-11 | 2020-08-04 | 98377 |
| PEDIAPRED | 5MG | SOLUTION | Discontinued | 2023-09-28 | 2023-12-19 | 205412 |
| PHISOHEX | 3% | EMULSION | Discontinued | 2017-03-20 | 2017-03-20 | 3696 |
| PLAVIX | 300MG | TABLET | To be discontinued | 2019-12-11 | 2019-12-11 | 100941 |
| RIFADIN | 150MG | CAPSULE | Discontinued | 2021-02-16 | 2021-02-16 | 134215 |
| RIFADIN | 300MG | CAPSULE | Discontinued | 2021-02-16 | 2021-02-16 | 134218 |
| RIFATER | 300MG 120MG 50MG | TABLET | Discontinued | 2017-03-20 | 2017-03-20 | 3688 |
| SECTRAL | 400MG | TABLET | Discontinued | 2017-03-20 | 2017-03-20 | 3692 |
| SECTRAL | 200MG | TABLET | Discontinued | 2018-07-09 | 2018-09-07 | 54767 |
| SECTRAL | 100MG | TABLET | Discontinued | 2018-09-17 | 2018-10-03 | 61609 |